U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07181187) titled 'Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo' on Sept. 12.
Brief Summary: This is a multicenter, randomized, double-blind, vehicle-controlled phase II study of MH004 Ointment with a 28-week open-label long-term safety extension period. The study was designed to evaluate the safety, tolerability, pharmacokinetics (PK), and primary efficacy of MH004 Ointment in adolescents and adults with vitiligo.
Study Start Date: March 26, 2024
Study Type: INTERVENTIONAL
Condition:
Vitiligo
Intervention:
DRUG: MH004 Ointment
MH004 1% ointment applied topically to the affected area as a thin film once or ...